Literature DB >> 8610729

Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data.

N M Gideon1, D M Mannino.   

Abstract

PURPOSE: We sought to describe sarcoidosis mortality in the United States from 1979 through 1991.
METHODS: We analyzed death certificate reports compiled by the National Center for Health Statistics for the period 1979 through 1991.
RESULTS: Of the 26,866,600 people who died during the study period, 9,014 had a diagnosis of sarcoidosis listed on their death certificates. We restricted our study group to 5,791 people who died because of sarcoidosis or one of its complications. Among men, age-adjusted mortality rates increased from 1.3 per 1,000,000 in 1979 to 1.6 per 1,000,000 in 1991, and among women, these rates increased from 1.9 per 1,000,000 in 1979 to 2.5 per 1,000,000 in 1991. Age-adjusted mortality rates were consistently higher among blacks than whites. Age-adjusted mortality rates stratified by race, varied by state. Among whites, the highest rates were in northern states, while among blacks, the highest rates were in the Middle Atlantic and northern Midwestern states.
CONCLUSIONS: Reported mortality due to sarcoidosis varies by region, sex, and race. We cannot determine whether these differences are related to characteristics of the disease, or problems in death certification and coding.

Entities:  

Mesh:

Year:  1996        PMID: 8610729     DOI: 10.1016/S0002-9343(97)89518-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  38 in total

Review 1.  A clinical approach to the use of methotrexate for sarcoidosis.

Authors:  R P Baughman; E E Lower
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Ill-defined and multiple causes on death certificates--a study of misclassification in mortality statistics.

Authors:  M D'Amico; E Agozzino; A Biagino; A Simonetti; P Marinelli
Journal:  Eur J Epidemiol       Date:  1999-02       Impact factor: 8.082

3.  Clinical manifestations of sarcoidosis among inner-city African-American dwellers.

Authors:  Gökhan M Mutlu; Israel Rubinstein
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

Review 4.  Disease Burden and Variability in Sarcoidosis.

Authors:  Alicia K Gerke; Marc A Judson; Yvette C Cozier; Daniel A Culver; Laura L Koth
Journal:  Ann Am Thorac Soc       Date:  2017-12

5.  Management of cardiac sarcoidosis in the United States: a Delphi study.

Authors:  Nabeel Y Hamzeh; Frederick S Wamboldt; Howard D Weinberger
Journal:  Chest       Date:  2011-07-07       Impact factor: 9.410

6.  Sarcoidosis in black women in the United States: data from the Black Women's Health Study.

Authors:  Yvette C Cozier; Jeffrey S Berman; Julie R Palmer; Deborah A Boggs; David M Serlin; Lynn Rosenberg
Journal:  Chest       Date:  2010-07-01       Impact factor: 9.410

Review 7.  Morbidity and mortality in sarcoidosis.

Authors:  Alicia K Gerke
Journal:  Curr Opin Pulm Med       Date:  2014-09       Impact factor: 3.155

8.  The logic and challenges of imaging sarcoidosis with whole body FDG PET.

Authors:  Roberto C Valentin; Pradeep Bhambhvani
Journal:  J Nucl Cardiol       Date:  2017-08-17       Impact factor: 5.952

9.  Refractory pulmonary sarcoidosis - proposal of a definition and recommendations for the diagnostic and therapeutic approach.

Authors:  Peter Korsten; Katharina Strohmayer; Robert P Baughman; Nadera J Sweiss
Journal:  Clin Pulm Med       Date:  2016-03

Review 10.  Sarcoidosis: an update for the primary care physician.

Authors:  Oluranti A Aladesanmi
Journal:  MedGenMed       Date:  2004-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.